Dimethyl fumarate Teva Umoja wa Ulaya - Kihungari - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetil-fumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunszuppresszánsok - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).